Janssen HLA - Search Results

1

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.

Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, Diaconescu G, Yim HJ, Heo J, Janczewska E, Wong A, Idriz N, Imamura M, Rizzardini G, Takaguchi K, Andreone P, Arbune M, Hou J, Park SJ, Vata A, Cremer J, Elston R, Lukić T, Quinn G, Maynard L, Kendrick S, Plein H, Campbell F, Paff M, Theodore D; B-Clear Study Group. Yuen MF, et al. Among authors: janssen hla. N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027. Epub 2022 Nov 8. N Engl J Med. 2022. PMID: 36346079 Clinical Trial.

2

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article.

3

Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays.

Janssen HL, Schoenmaker-Weber YA, Kruining H, Schalm SW, Heijtink RA. Janssen HL, et al. J Med Virol. 1993 Aug;40(4):307-12. doi: 10.1002/jmv.1890400408. J Med Virol. 1993. PMID: 8228921

4

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

5

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639

6

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

7

Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.

Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. J Viral Hepat. 2000 Sep;7(5):382-6. doi: 10.1046/j.1365-2893.2000.00246.x. J Viral Hepat. 2000. PMID: 10971827 Clinical Trial.

8

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

9

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.

van Nunen AB, Hansen BE, Suh DJ, Löhr HF, Chemello L, Fontaine H, Heathcote J, Song BC, Janssen HL, de Man RA, Schalm SW. van Nunen AB, et al. Gut. 2003 Mar;52(3):420-4. doi: 10.1136/gut.52.3.420. Gut. 2003. PMID: 12584227 Free PMC article.

10

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.

van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. van Zonneveld M, et al. J Viral Hepat. 2003 Jul;10(4):294-7. doi: 10.1046/j.1365-2893.2003.00440.x. J Viral Hepat. 2003. PMID: 12823596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

569 results

Search Page